» Articles » PMID: 23535595

Succinate is an Inflammatory Signal That Induces IL-1β Through HIF-1α

Abstract

Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis. Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1β but not tumour-necrosis factor-α in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and downregulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1β as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1β production during inflammation.

Citing Articles

Gut commensals-derived succinate impels colonic inflammation in ulcerative colitis.

Dalal R, Sadhu S, Batra A, Goswami S, Dandotiya J, K V V NPJ Biofilms Microbiomes. 2025; 11(1):44.

PMID: 40082467 PMC: 11906746. DOI: 10.1038/s41522-025-00672-3.


Lipin-1 restrains macrophage lipid synthesis to promote inflammation resolution.

Bamgbose T, Schilke R, Igiehon O, Nkadi E, Binwal M, Custis D J Immunol. 2025; 214(1):85-103.

PMID: 40073265 PMC: 11844145. DOI: 10.1093/jimmun/vkae010.


Dexamethasone has profound influence on the energy metabolism of porcine blood leukocytes and prevents the LPS-induced glycolytic switch.

Ma W, Brenmoehl J, Trakooljul N, Wimmers K, Murani E Front Immunol. 2025; 16:1514061.

PMID: 40070837 PMC: 11893826. DOI: 10.3389/fimmu.2025.1514061.


The role of mA modification during macrophage metabolic reprogramming in human diseases and animal models.

Wang H, Xu P, Yin K, Wang S Front Immunol. 2025; 16:1521196.

PMID: 40066451 PMC: 11891544. DOI: 10.3389/fimmu.2025.1521196.


Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


References
1.
Zhang W, Petrovic J, Callaghan D, Jones A, Cui H, Howlett C . Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J Neuroimmunol. 2006; 174(1-2):63-73. DOI: 10.1016/j.jneuroim.2006.01.014. View

2.
Pan H, Wu X . Hypoxia attenuates inflammatory mediators production induced by Acanthamoeba via Toll-like receptor 4 signaling in human corneal epithelial cells. Biochem Biophys Res Commun. 2012; 420(3):685-91. DOI: 10.1016/j.bbrc.2012.03.069. View

3.
Yan Y, Dalmasso G, Sitaraman S, Merlin D . Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma. Am J Physiol Gastrointest Liver Physiol. 2006; 292(2):G535-45. DOI: 10.1152/ajpgi.00385.2006. View

4.
Koivunen P, Hirsila M, Remes A, Hassinen I, Kivirikko K, Myllyharju J . Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2006; 282(7):4524-4532. DOI: 10.1074/jbc.M610415200. View

5.
Phillip West A, Brodsky I, Rahner C, Woo D, Erdjument-Bromage H, Tempst P . TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011; 472(7344):476-80. PMC: 3460538. DOI: 10.1038/nature09973. View